Haemodialysis without anticoagulant: Haemostasis parameters, fibrinogen kinetic, and dialysis efficiency

Nephrology Dialysis Transplantation

Volumn 12, Issue 1, 1997, Pages 106-110

  Romao Jr J E ^a   Fadil, M A ^a   Sabbaga, E ^a   Marcondes, M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anticoagulation; Fibrinogen; Fibrinolysis; Haemodialysis

Indexed keywords

ANTICOAGULANT AGENT; BICARBONATE; CREATININE; FIBRIN; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; FIBRINOGEN DEGRADATION PRODUCT; HEPARIN; IODINE 125; POTASSIUM; UREA;

ADULT; ARTICLE; BICARBONATE BLOOD LEVEL; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIALYSIS MEMBRANE; FEMALE; HEMATOCRIT; HEMODIALYSIS; HEMOSTASIS; HUMAN; MALE; PARTIAL THROMBOPLASTIN TIME; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; UREA BLOOD LEVEL; UREMIA;

ADULT; ANTICOAGULANTS; FEMALE; FIBRINOGEN; HEMORRHAGE; HEMOSTASIS; HUMANS; KIDNEY FAILURE, CHRONIC; KINETICS; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK FACTORS;

EID: 0031032625     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.1.106     Document Type: Article

References (42)

1. Ward DM, Mehta RL. Extracorporeal management of acute renal failure patients at high-risk of bleeding. Kidney Int 1993; 43: S237-S244
2. Gordon LA, Simon ER, Rukes JM, Richards V, Perkins HA. Studies in regional heparinization. N Engl J Med 1956; 255: 1063-1066
3. Maher JF, Lapierre L, Schreiner GE, Geiger M, Westvelt FB. Regional heparinization for hemodialysis. N Engl J Med 1963; 268: 451-456
4. Nakamoto S, Homes JH. Our experience in regional heparinization. Trans Am Soc Artif Intern Organs 1958; 4: 36-47
5. Swartz RD, Port FK. Preventing hemorrhage in high-risk hemodialysis: regional versus low-dose heparin. Kidney Int 1979; 16: 513-518
6. Farrell PC, Ward RA, Schindhelm K, Gotch FA. Precise anticoagulation for routine hemodialysis. J Lab Clin Med 1978; 92: 164-176
7. Gotch FA, Keen ML. Precise control of minimal heparinization for high risk hemodialysis. Trans Am Soc Artif Intern Organs 1977; 23: 168-176
8. Swartz RD. Hemorrhage during high-risk hemodialysis using controlled heparinization. Nephron 1981; 28: 65-69
9. Pinnick RV, Wiegmann TB, Diedrich DA. Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med 1983; 308: 258-261
10. Von Brecht JH, Flanigan MJ, Freeman RM, Lim VS. Regional anticoagulation: hemodialysis with hypertonic trisodium citrate. Am J Kidney Dis 1986; 8: 196-201
11. Zusman RM, Rubin RH, Cato AE, Cocchetto DM, Crow JW, Tolkoff-Rubin N. Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent. N Engl J Med 1981; 304: 934-939
12. 2) versus heparin in hemodialysis. Trans Am Soc Artif Intern Organs 1984; 30: 52-54
13. 2, prostacyclin) during high-risk hemodialysis: preventing further bleeding complications. J Clin Pharmacol 1988; 28: 818-825
14. Taenaka N, Terada N, Takahashi H et al. Hemodialysis using gabexate mesilate (FOY) in patients with a high bleeding risk. Crit Care Med 1986; 14: 481-483
15. Glaser P, Guesder R, Rouby JJ, Eurin VB. Hemodialysis without anticoagulant is possible. Lancet 1979; 2: 579-580
16. Romão JE Jr, Fadil MA, Zeratti AD, Sabbaga E. Hemodiálise sem heparina. Rev Hosp Clin Fac Med S Paulo 1983; 38: 70-72
17. Ivanovich P, Xu CG, Kwaan HC, Hathiwala S. Studies of coagulation and platelet functions in heparin-free hemodialysis. Nephron 1983; 33: 116-120
18. Agresti J, Conroy JD, Olshan A et al. Heparin-free hemodialysis with cuprophan hollow fiber dialysers by a frequent saline flush, high blood flow technique. Trans Am Soc Artif Intern Organs 1985; 31: 590-594
19. Barth RH, Sodden S, Berlyne GM. Heparin-free hemodialysis with a polyacrylonitrile membrane. Trans. Am Soc Artif Intern Organs 1989; 35: 597-600
20. Caruana RJ, Raja RM, Bush JV, Kramer MS, Goldstein SJ. Heparin free dialysis: Comparative data and results in high risk patients. Kidney Int. 1987; 31: 1351-1355
21. Casati S, Moia M, Graziani G et al. Hemodialysis without anticoagulant: efficiency and hemostatic aspects. Clin Nephrol 1984; 21: 102-105
22. Sanders PW, Taylor H, Curtis JJ. Hemodialysis without anticoagulation. Am J Kidney Dis 1985; 5: 32-35
23. Schwab SJ, Onorato JJ, Sharar LR, Dennis PA. Hemodialysis without anticoagulant: one-year prospective trial in hospitalized patients at risk for bleeding. Am J Med 1987; 83: 405-410
24. Ness PM. Dialysis and disseminated intravascular coagulation. Ann Intern Med 1981; 94: 543-544
25. Smitt GW, Moakee JL, Rudy CK, Vicks SL, Hamburger RL. Alterations in hemostatic parameters during hemodialysis with dialysers of different membrane composition and flow design. Platelet activation and factor VIII-related von Willebrand factor during hemodialysis. Am J Med 1987; 83: 411-418
26. Turney JH, Weston MJ. Dialysis without anticoagulants. Lancet 1981; 2: 693
27. 125-I. Estudo em individuos normais. Rev Hosp Clin Fac Med S Paulo 1976; 31: 99-104
28. Brecher G, Cronkitte EP. Morphology and enumeration of human blood platelets. J Appl Physiol 1950; 3: 365-377
29. Langdell RD, Wagner RH, Brinkhous RM. Determinacion del tiempo de tromboplastina parcial. In: Tocatins LM, Kazal LA, ed. Coagulacion del sangre. Hemorragie y Tromboses, Editorial Cientifico-Medica, Barcelona, 1969; 125-130
30. Breen FA, Tullis JL. Ethanol relation: a rapid screening test for intravascular coagulation. Ann Intern Med 1968; 69: 1197-1206
31. Quick AJ. The development and use of the prothrombin tests. Circulation 19: 1959; 92-96
32. Biggs R, Denson KWE, Akman N, Borrett R, Hadden M. Antithrombin III, antifactor Xa and heparin. Br J Haematol 1970; 19: 283-305
33. Kelleher SP, Schulman G. Severe metabolic alkalosis complicating regional citrate hemodialysis. Am J Kidney Dis 1987; 9: 235-236
34. Morita Y, Johnson RW, Dorn RE. Regional anticoagulation during hemodialysis using citrate. Am J Med Sci 1961; 242: 32-37
35. Knudsen F, Nielsen AH, Kornerup HJ, Pedersen JC, Dyerberg J. Epoprostenol as sole antithrombotic treatment during hemodialysis. Lancet 1984; 1: 235-236
36. Lindsey RM, Prentice CRM, Davidson JF, Burton JA, McNicol GP. Haemostatic changes during dialysis associated with thrombus formation on dialysis membranes. Br Med J 1972; 4: 454-458
37. 125. Minerva Nefrol 1977; 24: 205-212
38. Gunnarsson B, Asaba H, Kiibus A et al. Fibrin deposition in disposable dialysers before and after re-use. Clin Nephrol 1979; 12: 117-122
39. Gunnarsson B, Asaba H, Dawidson S et al. The effects of three different heparin regimes on heparin concentrations in plasma and fibrin formation in dialysers. Clin Nephrol 1981; 15: 135-142
40. 125I-fibrinogen in metabolic studies. J Clin Pathol 1975; 28: 487-491
41. 125I-fibrinogen. Thromb Res 1977; 1: 235-243
42. Harker LA, Slichter SJ. Platelet and fibrinogen consumption in man. N Engl J Med 1972; 287: 999-1003